ALCON INC. CORPORATE


Associated tags: Optical, Health, Alcon, Science, Patient, NYSE, Eye, IOL, Medical device, Surgery, Research

Locations: TEXAS, UNITED STATES, NORTH AMERICA, EUROPE, SWITZERLAND, CANADA, FORT WORTH, INDIA, SINGAPORE, ARGENTINA, GREECE, ITALY, NETHERLANDS, BRAZIL, GERMANY, SPAIN, AUSTRIA, AUSTRALIA, BELGIUM, NEW ZEALAND, PORTUGAL, ONTARIO, FRANCE, JAPAN, CHINA, ASIA PACIFIC

Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India

Retrieved on: 
Tuesday, March 12, 2024

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the Clareon® Family of intraocular lenses (IOLs) in India.

Key Points: 
  • Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the Clareon® Family of intraocular lenses (IOLs) in India.
  • At Alcon, we are consistently pushing the boundaries to deliver transformational innovation to cataract surgeons and their patients,” said Amar Vyas, Country Head of Alcon India.
  • “Clareon builds on Alcon’s long legacy of IOL innovation and is the result of robust R&D efforts at every level—inventive material science, advanced manufacturing techniques and novel delivery systems.
  • *,β,19,20 Clareon IOLs have been extensively researched, with inclusions in 30 published studies worldwide.

Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone

Retrieved on: 
Wednesday, March 6, 2024

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity extended depth of focus (EDOF) intraocular lens (IOL) has surpassed more than one million implants worldwide.

Key Points: 
  • Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity extended depth of focus (EDOF) intraocular lens (IOL) has surpassed more than one million implants worldwide.
  • Recent, large-scale real-world data underscores the impact of Vivity on patients across the globe.
  • Vivity is available in more than 80 countries, including Australia, Brazil, Canada, China, France, Germany, Japan, India, Italy, South Korea, Spain, U.K. and U.S. Alcon offers a family of leading IOLs designed to meet the unique vision needs of patients, including Vivity and PanOptix®—the most implanted PCIOLs worldwide—as well as Monofocal and Toric options.
  • PanOptix surpassed 1M implants in early 2022, and is the most implanted trifocal worldwide.5,6 For more information, please visit www.alcon.ca .

Cataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependence

Retrieved on: 
Saturday, September 9, 2023

Data from more than 900 cataract patients demonstrated sustained clinical performance, high patient satisfaction and reduced dependence upon spectacles (glasses).

Key Points: 
  • Data from more than 900 cataract patients demonstrated sustained clinical performance, high patient satisfaction and reduced dependence upon spectacles (glasses).
  • Evidence also suggested that AcrySof® IQ Vivity® can be used successfully in a broad range of patients, providing surgeons and patients with additional treatment options.
  • “Since its introduction, AcrySof® IQ Vivity® has been a disruptive technology—and an innovation we are very proud of as a company.
  • AcrySof® IQ Vivity® can help to meet patient demands and expectations related to performance, quality of life and spectacle independence.

Alcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical Teams

Retrieved on: 
Wednesday, September 6, 2023

“Alcon is driven by our purpose to help people see brilliantly.

Key Points: 
  • “Alcon is driven by our purpose to help people see brilliantly.
  • Introducing cutting-edge innovation and breakthrough technology has helped us bring our purpose to life for more than 75 years,” said Sunil Vasanth, VP, Europe Surgical Franchise, Alcon.
  • Visitors may download clinical science publications, submit grant applications for Investigator-Initiated Trials (IITs) and apply for independent medical education support, among other activities.
  • Please note that product-related promotion of Medical Devices to non-HCPs may be subject to restrictions based on local rules and regulations.

Alcon Advances Company’s Social Impact Through Global Volunteerism

Retrieved on: 
Monday, May 22, 2023

Working together to make a brilliant impact in the communities where they live and work, thousands of Alcon associates from 57 locations around the world are participating in Alcon in Alcon (AiA), a company-wide volunteering initiative.

Key Points: 
  • Working together to make a brilliant impact in the communities where they live and work, thousands of Alcon associates from 57 locations around the world are participating in Alcon in Alcon (AiA), a company-wide volunteering initiative.
  • “I am proud to see our associates come together for AiA with such an intense focus on making an impact on their communities,” said Charles Herget, Global Head of Social Impact and Sustainability at Alcon.
  • Alcon has a culture deeply rooted in working together to make a brilliant impact.
  • Alcon associates are dedicated to serving their communities on an ongoing basis and helping bring people around the world better access to quality eye care.

Alcon’s “The Lens” Interactive Compliance Training Experience Receives Coveted Anthem Award

Retrieved on: 
Thursday, March 23, 2023

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that its interactive compliance training video experience, The Lens, has been named Best Special Workforce Initiative: Health in the 2nd Annual Anthem Awards.

Key Points: 
  • Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that its interactive compliance training video experience, The Lens, has been named Best Special Workforce Initiative: Health in the 2nd Annual Anthem Awards.
  • Launched in 2021 by The Webby Awards, The Anthem Award winners are selected by the International Academy of Digital Arts and Sciences.
  • The interactive compliance experience was developed by Alcon’s Legal and Compliance team along with Labyrinth Training – an innovative company that combines first rate storytelling with award-winning interactive design to bring corporate policies to life.
  • “We are honored to be recognized by The Anthem Awards for our company-wide compliance training program, The Lens,” said Royce Bedward, Senior Vice President, General Counsel and Corporate Secretary for Alcon.

Alcon to Debut TOTAL30 for Astigmatism, Dry Eye and Ocular Health Innovations at SECO 2023

Retrieved on: 
Wednesday, March 1, 2023

Alcon will debut TOTAL30® for Astigmatism, the first and only reusable Water Gradient toric lens on the market,1 now available to Eye Care Professionals (ECPs) across the U.S.

Key Points: 
  • Alcon will debut TOTAL30® for Astigmatism, the first and only reusable Water Gradient toric lens on the market,1 now available to Eye Care Professionals (ECPs) across the U.S.
  • In addition to showcasing its latest innovations, Alcon will present its newest clinical data and research findings across its vision care, dry eye, allergy and ocular health portfolios.
  • “Alcon is thrilled to be celebrating 100 years of SECO,” said Sean Clark, General Manager, U.S.
  • Visit Alcon booth #1138 for refreshments, samples of SYSTANE HYDRATION PF, Pataday, and TOTAL30 for Astigmatism, and literature on Alcon’s products.